Supernus Pharmaceuticals INC
Experience in developing and commercializing products that treat central nervous system
Based in MD
AI Overview
With $320K in lobbying spend across 17 quarterly filings, Supernus Pharmaceuticals INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2022 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $60K |
| 2023 | $80K |
| 2024 | $100K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Supernus Pharmaceuticals INC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues
Issues related to Medicare Part B and Part D and issues related to the pharmaceutical industry
issues related to the pharmaceutical industry
issues related to Medicare drug reimbursement
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.